Bone Biologics Corporation (BBLG) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Bone Biologics Corporation (BBLG) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.1M, listed on NASDAQ, employing roughly 2 people, carrying a beta of 0.53 to the broader market. Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Led by Jeffrey Frelick, public since 2021-10-13.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for BBLG as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →